Continuing Medical Education (CME)
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality, and scientific integrity of the CME activity.
The American Society of Cataract and Refractive Surgery designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™, Physicians should claim credit commensurate with the extent of their participation in the activity. Physicians may claim credit for participation as follows:
Thursday:max 6 credits
Friday:max 5.50 credits
Saturday:max 4.50 credits
Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credit™. Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits.
Notice of Off-Label Use Presentations
This program may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he/she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products, or techniques presented.
Educational ObjectivesTarget Audience:
This educational activity is intended for ophthalmologists with an interest in anterior segment surgery.
Ophthalmologist attending this meeting will:
Implement best practices in the diagnosis, preparation for, and surgical management of complex and challenging cataract and anterior segment cases.
Describe and integrate key elements and recent advances to improve cataract refractive outcomes to meet increased patient expectations, including evaluating and integrating advanced IOL’s power calculation methods, techniques and technologies.
Compare advances in therapeutics and surgical management options for the treatment of glaucoma.
Improve practice protocols for the screening, diagnosis, and classification of corneal and external disease, including ocular surface and dry eye disease, evaluate the effects of various therapeutic classes and surgical treatments, and integrate consistent treatment regimens.
Analyze the efficacy of emerging technologies in corneal refractive surgery.